DIATHERIX EUROFINS, LLC, headquartered in the United States, is a prominent player in the molecular diagnostics industry. Founded in 2013, the company has rapidly established itself as a leader in advanced diagnostic testing, particularly in infectious diseases and genetic disorders. With a focus on innovative solutions, DIATHERIX EUROFINS offers a unique range of services, including multiplex testing that allows for the simultaneous detection of multiple pathogens. The company operates primarily in the US, with a growing presence in international markets. Notable achievements include the development of proprietary testing platforms that enhance accuracy and speed in diagnostics. As part of the Eurofins Scientific group, DIATHERIX EUROFINS is well-positioned in the market, recognised for its commitment to quality and cutting-edge technology in the healthcare sector.
How does DIATHERIX EUROFINS, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
DIATHERIX EUROFINS, LLC's score of 78 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
DIATHERIX EUROFINS, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family that includes Eurofins Scientific SE, from which it inherits emissions data and climate commitments. As a current subsidiary of Eurofins Scientific SE, DIATHERIX EUROFINS, LLC aligns with the sustainability initiatives and targets set by its parent organisation. Eurofins Scientific SE has established various climate commitments, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to drive significant reductions in greenhouse gas emissions across their operations. While specific reduction targets for DIATHERIX EUROFINS, LLC are not detailed, the overarching goals from Eurofins Scientific SE suggest a commitment to improving environmental performance and reducing carbon footprints. The company is expected to adhere to these industry-standard climate strategies, contributing to broader efforts in mitigating climate change impacts. In summary, while DIATHERIX EUROFINS, LLC does not provide specific emissions data or reduction targets, it is integrated into the sustainability framework of Eurofins Scientific SE, which actively pursues climate commitments and emissions reductions.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 72,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 155,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 311,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
DIATHERIX EUROFINS, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.